Personal tools

MCL coexpression mm9:255: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 6: Line 6:
|ontology_enrichment_disease=
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0002390!1.36e-11!45;UBERON:0003061!1.36e-11!45;UBERON:0002193!1.75e-10!48;UBERON:0002405!1.75e-10!48;UBERON:0004177!2.22e-09!29;UBERON:0005057!2.22e-09!29;UBERON:0002384!6.57e-09!46;UBERON:0000077!4.36e-07!35
|ontology_enrichment_uberon=UBERON:0002390!1.36e-11!45;UBERON:0003061!1.36e-11!45;UBERON:0002193!1.75e-10!48;UBERON:0002405!1.75e-10!48;UBERON:0004177!2.22e-09!29;UBERON:0005057!2.22e-09!29;UBERON:0002384!6.57e-09!46;UBERON:0000077!4.36e-07!35
|tfbs_overrepresentation_for_novel_motifs=0.2005,0.345537,0.692708,0.531249,0.379978,0.562772,0.121436,0.744315,0.342458,0.208435,0.325626,0.368534,0.745597,0.402403,0.422447,0,0.251083,0.600021,0.928387,0.574452,0.321036,0.492568,0.401126,0.376135,0.18065,0.441914,0.251881,0.609434,0.267596,0.419507,0.274535,0.870912,0.354863,0.526942,1.40613,0.0885186,0.559024,0.36358,0.282212,0.221237,0.189193,0.993144,0.192043,0.223829,0.603162,0.235475,0.196567,0.0939238,0.074965,0.507079,0.671323,0.93522,0.389635,0.440493,0.45514,0.818582,0.288046,0.351141,0.577971,1.32042,0.31094,0.495729,0.377986,0.230901,0.138355,0.259509,0.573087,0.894999,0.307386,0.756737,0.354261,0.332034,1.17993,0.483599,0.545701,0.0947976,0.012801,0.553945,0.297944,0.596416,0.0847125,0.263556,0.1644,0.161297,0.387484,0.130296,0.106188,0.00818014,0.19978,1.05033,0.635424,0.391521,0.336244,0.394854,0.273282,0.0391609,0.0755433,0.338434,0.196734,0.0195875,0.332674,0.326093,1.0902,0.239164,0.238425,1.47634,0.769646,0.307199,0.337745,0.324305,0.428415,0.427455,0.94135,0.680399,0.64179,0.90877,0.597824,0.539405,0.252011,0.546056,0.488218,0.216549,0.44457,0.552537,0.691048,0.300729,0.12586,0.881336,0.571744,0.208592,0.411944,0.0679138,0.545694,0.851896,0.661372,0.0363506,0.459995,0.592592,0.616948,1.40994,1.01963,0.577263,0.462236,0.334426,0.233904,0.590458,0.19861,1.3709,0.464877,0.635114,0.15772,1.2046,1.12448,0.118879,0.430809,1.27368,0.160157,0.0968826,0.0535441,0.798202,0.625497,1.00477,0.301065,0.190434,0.654652,0.831519,0.555095,0.366357,0.108745
}}
}}

Revision as of 18:03, 26 November 2012


Phase1 CAGE Peaks

 Short description
Mm9::chr10:76688454..76688462,+p@chr10:76688454..76688462
+
Mm9::chr10:76688464..76688474,+p@chr10:76688464..76688474
+
Mm9::chr11:102177974..102177992,-p17@Ubtf
Mm9::chr11:102331415..102331424,-p9@Itga2b
Mm9::chr11:106362222..106362239,+p1@Snord104
Mm9::chr11:115938300..115938341,-p3@Unc13d
Mm9::chr11:6428785..6428810,-p2@ENSMUST00000147762
p2@uc007hyu.1
Mm9::chr17:24664870..24664880,-p4@Traf7
Mm9::chr17:33918132..33918225,-p2@Angptl4
Mm9::chr17:34258889..34258917,-p10@Brd2
Mm9::chr17:39985193..39985213,+p@chr17:39985193..39985213
+
Mm9::chr18:12321944..12321948,+p1@ENSMUST00000122799
Mm9::chr18:34671622..34671653,-p@chr18:34671622..34671653
-
Mm9::chr19:8797968..8798004,+p1@Snhg1
Mm9::chr2:10814902..10814910,+p@chr2:10814902..10814910
+
Mm9::chr2:152011439..152011450,-p1@ENSMUST00000117430
Mm9::chr2:156853485..156853494,-p13@9830001H06Rik
Mm9::chr3:121948220..121948250,-p@chr3:121948220..121948250
-
Mm9::chr3:153575905..153575924,-p1@Rabggtb
Mm9::chr4:106323692..106323725,+p1@Pars2
Mm9::chr4:131909538..131909556,-p1@ENSMUST00000151374
Mm9::chr4:43505923..43505937,-p1@Rmrp
Mm9::chr5:139853642..139853664,+p2@D830046C22Rik
Mm9::chr5:65875277..65875315,-p@chr5:65875277..65875315
-
Mm9::chr6:112996157..112996171,-p@chr6:112996157..112996171
-
Mm9::chr6:88148650..88148669,+p1@Gata2
Mm9::chr7:133646139..133646169,+p@chr7:133646139..133646169
+
Mm9::chr7:75334450..75334472,+p@chr7:75334450..75334472
+
Mm9::chr8:87188142..87188156,+p@chr8:87188142..87188156
+
Mm9::chr9:108007205..108007233,-p@chr9:108007205..108007233
-
Mm9::chr9:43033167..43033191,-p@chr9:43033167..43033191
-
Mm9::chrX:133654344..133654358,-p2@Esx1
Mm9::chrX:35682209..35682211,+p@chrX:35682209..35682211
+


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data

GO IDGO nameFDR corrected p-value
GO:0006909phagocytosis0.0468125249051673
GO:0051005negative regulation of lipoprotein lipase activity0.0468125249051673
GO:0002432granuloma formation0.0468125249051673
GO:0004827proline-tRNA ligase activity0.0468125249051673
GO:0006433prolyl-tRNA aminoacylation0.0468125249051673
GO:0051004regulation of lipoprotein lipase activity0.0468125249051673
GO:0002544chronic inflammatory response0.0468125249051673
GO:0043320natural killer cell degranulation0.0468125249051673



Relative expression of the co-expression cluster over median <br>Analyst:




Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>

Uber Anatomy
Ontology termp-valuen
hematopoietic system1.36e-1145
blood island1.36e-1145
hemolymphoid system1.75e-1048
immune system1.75e-1048
hemopoietic organ2.22e-0929
immune organ2.22e-0929
connective tissue6.57e-0946
mixed endoderm/mesoderm-derived structure4.36e-0735


TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data

Novel motifs




JASPAR motifs


Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}

Retrieved from "http://f5-webapp4.gsc.riken.jp/resource_browser/index.php?title=MCL_coexpression_mm9:255&oldid=2561475"